Logo image of SRPT

SAREPTA THERAPEUTICS INC (SRPT) Stock Analyst Ratings

NASDAQ:SRPT - Nasdaq - US8036071004 - Common Stock - Currency: USD

114.08  +0.27 (+0.24%)

After market: 114.08 0 (0%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to SRPT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 187.88. This target is 64.69% above the current price.
SRPT was analyzed by 29 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SRPT.
In the previous month the buy percentage consensus was at a similar level.
SRPT was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
SRPT Historical Analyst RatingsSRPT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -97 -88 -79 -70 -61 -52 -43 -34 -25 -16 -7 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 114.0875.75198.90187.88227.85 - -33.60% 74.35% 64.69% 99.73%
SRPT Current Analyst RatingSRPT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-01-30 HC Wainwright & Co. Reiterate Sell -> Sell
2025-01-27 Needham Reiterate Buy -> Buy
2025-01-15 HC Wainwright & Co. Reiterate Sell -> Sell
2025-01-14 Needham Reiterate Buy -> Buy
2024-12-19 HC Wainwright & Co. Reiterate Sell -> Sell
2024-12-03 HC Wainwright & Co. Maintains Sell -> Sell
2024-11-27 Needham Maintains Buy -> Buy
2024-11-27 Piper Sandler Maintains Overweight -> Overweight
2024-11-25 HC Wainwright & Co. Initiate Sell
2024-11-07 Cantor Fitzgerald Upgrade Neutral -> Overweight
2024-11-07 Guggenheim Maintains Buy -> Buy
2024-11-07 Needham Reiterate Buy -> Buy
2024-11-07 Evercore ISI Group Maintains Outperform -> Outperform
2024-11-07 Baird Maintains Outperform -> Outperform
2024-10-21 RBC Capital Reiterate Outperform -> Outperform
2024-10-21 Jefferies Initiate Buy
2024-10-14 Needham Reiterate Buy -> Buy
2024-10-10 Raymond James Reiterate Outperform
2024-10-04 RBC Capital Maintains Outperform -> Outperform
2024-09-20 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-09-19 RBC Capital Reiterate Outperform -> Outperform
2024-09-06 RBC Capital Reiterate Outperform -> Outperform
2024-08-15 RBC Capital Reiterate Outperform -> Outperform
2024-08-08 Cantor Fitzgerald Maintains Neutral -> Neutral
2024-08-08 RBC Capital Maintains Outperform -> Outperform
2024-08-08 Barclays Maintains Overweight -> Overweight
2024-08-08 Evercore ISI Group Upgrade In-Line -> Outperform
2024-08-08 Piper Sandler Maintains Overweight -> Overweight
2024-08-08 Citigroup Maintains Neutral -> Neutral
2024-07-29 RBC Capital Upgrade Sector Perform -> Outperform